- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Latest Conference Articles
.jpg?w=350&fit=crop&auto=format)
HFSA 2021: The Physician Assistants Experience, With Viet Le, PA-C
September 22nd 2021
Heart Failure Society of America
Viet Le, PA-C, details his experience at the Heart Failure Society of America annual meeting from the perspective of a physician assistant.
Digital Apps Could Improve Outcomes, Adherence Among Patients With Heart Failure
September 17th 2021
Heart Failure Society of America
Data from the CONNECT-HF trial from HFSA 2021 suggest use of a digital tool designed to improve adherence could contribute to improving outcomes among patients discharged from the hospital with heart failure with reduced ejection fraction.
.jpeg?w=350&fit=crop&auto=format)
Aficamten Shows Potential for Hypertrophic Cardiomyopathy in REDWOOD-HCM
September 15th 2021
Heart Failure Society of America
Presented at HFSA 2021, results of REDWOOD-HCM provide insight into the effects of the oral selective cardiac myosin inhibitor aficamten in patients with obstructive hypertrophic cardiomyopathy.
PRESERVED-HF: Dapagliflozin Reduces Symptom Burden, Physical Limitations in HFpEF
September 14th 2021
Heart Failure Society of America
Presented at HFSA 2021, PRESERVED-HF provides evidence suggesting dapagliflozin use was associated with improvements in KCCQ symptom score and 6-minute walking distance in patients with heart failure with preserved ejection fraction.
ESC Congress 2021 Expert Perspective: Top 5 Studies With Brett Nowlan, MD
September 2nd 2021
European Society of Cardiology Congress
Practical Cardiology editorial advisory board member Brett Nowlan, MD, compiled a top 5 list of studies he thought were noteworthy from ESC Congress 2021 and offers his perspective on why he chose each study.
ESC Congress 2021: Top Trials Slideshow
August 31st 2021
European Society of Cardiology Congress
Every year, ESC Congress provides clinicians and researchers with a glimpse into the latest data from clinical trials. Our editorial staff's top picks for new trials from ESC Congress 2021 conference includes EMPEROR-Preserved, FIGARO-DKD, SSaSS, MASTER DAPT, and the LOOP Study.
ENVISAGE-TAVI AF: Clinical Implications and Next Steps, With George Dangas, MD, PhD
August 31st 2021
European Society of Cardiology Congress
George Dangas, MD, PhD, discusses the results of ENVISAGE-TAVI AF and provides perspective into the priorities of investigators as they plan and conduct additional analyses of the trial.
.jpeg?w=350&fit=crop&auto=format)
ESC Releases Updated Cardiovascular Disease Prevention Guidelines
August 31st 2021
European Society of Cardiology Congress
Gregory Weiss, MD, provides an overview of the updated cardiovascular disease prevention guidelines from the European Society of Cardiology, which were released at ESC Congress 2021.
TWILIGHT-Stent: Results Consistent Regardless of Stent Type
August 31st 2021
European Society of Cardiology Congress
Results of the TWILIGHT-Stent study provide insight into the impact of stent type on effects of ticagrelor monotherapy compared against ticagrelor plus aspirin among patients within the original TWILIGHT trial.
.jpeg?w=350&fit=crop&auto=format)
Amplatzer Amulet Outperforms Watchman Device for LAA Occlusion in Head-to-Head Trial
August 30th 2021
European Society of Cardiology Congress
The Amulet IDE Trial is the first trial to offer a head-to-head comparison of the Amplatzer Amulet occluder from Abbot against the Watchman device from Boston Scientific for left atrial appendage occlusion.